Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Dec 15;19:1533033820964222. doi: 10.1177/1533033820964222

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).

PMC Copyright notice

Figure 4. — The association between serum miR-762 and gefitinib-resistance as well as OS/RFS of NSCLC. (A) A higher percentage of gefitinib-resistance NSCLC cases was found in the high serum miR-762 group. (B) The NSCLC patients in the high serum miR-762 group had shorter OS than the patients in the low serum miR-762 group. (C) The NSCLC patients in the high serum miR-762 group had worse RFS than those in the low serum miR-762 group.